Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.

Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.

Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.

Potential Risks of TTTS

If left untreated, TTTS can have devastating consequences. Medical research indicates that:

• 90% of the cases of untreated TTTS lead to loss of one or both twins.
• Despite treatment, only a 70% survival rate for both twins is assured.
• Severe forms can result in preterm labor, cardiac failure in the recipient twin, and organ failure in the donor twin.
• Complications in long-term survivors include neurological damage and developmental delay in surviving infants.

TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.

Why Identical Twin Pregnancies Are More Complicated

Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.

Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.

Other Twin Pregnancy Health Risks

Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:

1. Premature Birth

Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.

2. Gestational Hypertension and Preeclampsia

Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.

3. Anemia

Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.

4. Birth Defects

According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.

5. Amniotic Fluid Imbalances

When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.

6. Postpartum Hemorrhage

Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.

Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."

Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.

Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.

The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.

The Ebola outbreak in the Democratic Republic of Congo (DRC) has become the deadliest one in the country’s history, with the death toll reaching 2,325, according to the latest reports.

The number has now surpassed the 2,299 deaths recorded during the 2018–2020 Ebola outbreak, which had previously been the country’s worst. The current outbreak has also become the largest in the DRC by number of confirmed cases, with 4,945 infections recorded so far.

The latest figures indicate that the outbreak has reached another grim milestone just three months after it was officially declared on May 15.

Ebola Is Spreading Rapidly

The DRC’s National Public Health Institute reported 101 new confirmed cases in the 24 hours leading up to its latest update, highlighting how quickly transmission is continuing.

The outbreak was first detected in Ituri province, but the virus has since spread to six provinces, including North Kivu, South Kivu, Haut-Uele, Tshopo and Bas-Uele. More than 3,400 cases have been reported in Ituri alone.

The United Nations has described the outbreak as the fastest-growing Ebola epidemic on record.

“Ebola is winning in the Democratic Republic of the Congo. We cannot let the virus outrun our response,” UN humanitarian chief Tom Fletcher said, calling for “speed, scale, and solidarity” before the outbreak gets even further ahead of containment efforts.

Also read: Ebola Outbreak Is Claiming 1 Life Every 30 Minutes In DR Congo: UN Humanitarian Official

The Most Deadly Outbreak

One of the biggest reasons behind rapid transmission is that people are still being diagnosed too late. Thomas Parisch, a public health specialist with Médecins Sans Frontières, said that normally the proportion of people dying should fall as outbreaks progress because contact tracing improves and patients receive treatment earlier.

“Instead, we're still seeing many cases detected very late,” he said, with some infections only being identified after patients have died in their communities.

The case-fatality ratio has climbed from around 20% in early June to approximately 46%, according to Reuters.

That does not mean the virus itself has become more lethal. Rather, the increase is a warning that many patients are reaching healthcare facilities too late for treatment to be effective.

Also read: Ebola 2026 Outbreak Spreading Faster Than Any Before, On Track To Become Deadliest: WHO Chief

No Approved Vaccine

The current outbreak is being caused by the Bundibugyo species of Ebola, a relatively rare strain.

Unlike the Zaire species responsible for several previous major Ebola outbreaks, Bundibugyo currently has no approved vaccine or specific treatment. WHO says experimental vaccines and treatments are being investigated, but they remain under evaluation.

This makes early diagnosis, isolation, contact tracing and supportive medical care particularly important.

The outbreak is also unfolding in an extremely difficult environment. Conflict, population movement, weak healthcare infrastructure, misinformation and shortages of resources are making it harder for health teams to identify and isolate infections quickly. Health workers have also demonstrated strikes due to unpaid wages.

Also read: Amid Rapidly Expanding Ebola Outbreak, DR Congo Is Seeing An Alarming Increase In Maternal Deaths; Here's Why

Efforts Towards Containing The Outbreak

Despite the challenges, WHO chief Dr Tedros Adhanom Ghebreyesus said significant progress has been made towards containing and eradicating the virus. It includes:

• More than 21,000 community health workers have been trained.
• Treatment centres, safe burial teams, laboratories and community engagement teams are operating across the affected provinces, reaching hundreds of thousands of people.
• A total of 886 patients have recovered, even without specific therapeutics and vaccines, which are progressing through trials.
• For the first time, two vaccines specifically designed against Bundibugyo virus have entered Phase 1 safety trials in humans.
• Two new animal studies of a vaccine against Zaire ebolavirus — the more common species — have shown promising evidence of cross-protection in animals, Tedros said.

In an early trial, scientists are testing the possibility if a vaccine could intercept pancreatic cancer, one of the deadliest cancers in the US, at an early stage and prevent it from becoming invasive.

The trial involves people who were considered at high risk of pancreatic cancer and already had small abnormalities, like cysts, in their pancreas.

The experimental vaccine, called mKRAS-VAX, is designed to train the immune system to recognise mutated KRAS proteins, which are found in most pancreatic ductal adenocarcinomas, the most common type of pancreatic cancer.

The findings, published in Cancer Discovery, offer an intriguing new approach in which instead of waiting for pancreatic cancer to appear and then treating it, researchers are attempting to intercept the disease at its earliest stages.

How Does The Vaccine Work?

Also read: UK Set To Implement Stricter Protocol For Prostate Cancer Testing; Who Is Eligible To Get Tested?

Pancreatic cancer often develops gradually from precursor lesions. Some of these lesions can contain mutations in the KRAS gene, which can drive the development of the disease.

The mKRAS-VAX vaccine contains synthetic peptides targeting six common KRAS mutations. The goal is to teach T cells to recognise cells carrying these abnormal proteins and destroy them before they progress into cancer.

Unlike traditional vaccines against infections, this is a therapeutic cancer vaccine, meaning it is designed to stimulate the patient's immune system against targets related to cancer.

Findings From The Early Trial

Also read: Following A Western Diet? Changes In Your Gut Bacteria Could Increase Colon Cancer Risk

The Phase 1 study involved 20 people who had either a family history or genetic predisposition to pancreatic cancer and had a pancreatic abnormality detected on imaging.

The vaccine produced mutant-KRAS-specific T-cell responses in 18 of the 20 participants, or 90%. These immune responses persisted for as long as two years. Researchers also saw an intriguing change in pancreatic cysts.

At a median follow-up of 16.5 months, 37.5% of participants experienced cyst reduction or complete resolution. Among a comparable group of unvaccinated people, the figure was 6.8%.

None of the vaccinated participants had developed pancreatic ductal adenocarcinoma during the study follow-up. However, this does not prove that the vaccine prevents pancreatic cancer.

The study was small, early-stage and primarily designed to examine safety and whether the vaccine could generate an immune response.

“We are very excited about these results,” pancreatic cancer vaccine researcher Elizabeth Jaffee said.

More About Pancreatic Cysts

The researchers are interested in whether vaccination could intervene during this window, before malignant cells are formed.

That is particularly significant because pancreatic cancer is notoriously difficult to detect early and remains one of the deadliest cancers.

The long-term ambition is to develop a vaccine to prevent pancreatic cancer but researchers are not there yet.

Jaffee described the field as “nascent” and said she is “cautiously optimistic,” while emphasising that these small Phase 1 studies are not designed to establish whether the vaccines improve survival or prevent cancer.

Larger Phase 2 studies will be needed to determine whether the early immune responses translate into meaningful clinical benefits.

Endometriosis is usually characterised by painful periods, chronic pelvic pain and fertility issues. But a new study suggests the condition may also be linked to a significantly higher risk of developing type 2 diabetes.

Researchers found that women with endometriosis had a 46% higher risk of type 2 diabetes compared with women without the condition.

The findings come from one of the largest studies to examine the relationship between the two conditions, adding a new dimension to the adverse effects of endometriosis.

What Did The Study Find?

Also read: 'My Periods Are Painful' Is Not Always Normal: When Could It Be A Sign of Endometriosis?

Researchers studied health records from nearly 3 million women in the Utah Population Database, covering the period from 1996 to 2021. Almost 100,000 women were diagnosed with endometriosis.

After accounting for factors including age, race and body mass index, women with endometriosis were found to have a 46% greater risk of developing type 2 diabetes than women without the condition. The researchers also found that the association differed depending on the type of endometriosis.

Additionally, the risk of type 2 diabetes was higher across several subtypes, including superficial peritoneal, ovarian and deep infiltrating endometriosis.

The strongest association was seen in women with endometriosis outside the usual pelvic sites, where the risk was about twice as high. Adenomyosis was also associated with an increased risk.

Why Could The Two Disorders Be Connected?

Also read: Maternal Anemia: Why It’s A Major Pregnancy Risk For Indian Women And How to Prevent It

Chronic inflammation could be the reason why the two disorders could be connected. Endometriosis is an inflammatory disease in which tissue resembling the lining of the uterus grows outside the uterus.

Persistent inflammation can affect several systems in the body, while inflammation and poor insulin sensitivity could lead to type 2 diabetes.

“Previous studies largely evaluated endometriosis as a single condition and generally reported little or no overall association with type 2 diabetes,” said Fuzak Nunziato, lead author of the study. “Our findings add to a growing understanding that endometriosis may affect more than reproductive health alone.”

Despite the strong observation, it is to be noted that study found an association, meaning women with endometriosis were more likely to develop type 2 diabetes. It does not prove that endometriosis directly causes type 2 diabetes.

The study was also retrospective, meaning researchers looked back at archival health records rather than assigning participants to groups and studying them prospectively.

A large prospective research published in 2021 found no overall significant increase in type 2 diabetes among women with laparoscopically confirmed endometriosis, although it did find modestly higher risks among certain groups, including women who were not obese.

The association was particularly notable among premenopausal women and women without obesity - groups that are not normally not considered to be at the highest risk for type 2 diabetes.

If further research solidifies the the link, researchers say women with endometriosis could potentially benefit from greater awareness of metabolic health and earlier identification of diabetes risk.